Scarica l'app Stockscreener
56.25
6.15%
3.26
Dopo l'orario di chiusura:
56.25
Rhythm Pharmaceuticals Inc Borsa (RYTM) Ultime notizie
Rhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 1-Year HighTime to Buy? - MarketBeat
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update - GlobeNewswire
Rhythm Pharma stock soars to all-time high of $55.65 - Investing.com
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve
Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 7.4%Here's Why - MarketBeat
Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024 - The Manila Times
What's Next: Rhythm Pharmaceuticals's Earnings Preview - Benzinga
(RYTM) Investment Analysis - Stock Traders Daily
Assenagon Asset Management S.A. Decreases Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Nisa Investment Advisors LLC Has $3.47 Million Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Needham & Company LLC Reaffirms Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN
Rhythm Pharmaceuticals (RYTM) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Rhythm Pharma, Axovia Therapeutics Launch Joint Research Collaboration for Bardet-Biedl Syndrome - Medical Dialogues
Critical Insights From Rhythm Pharmaceuticals Analyst Ratings: What You Need To Know - Benzinga
HC Wainwright Reiterates "Buy" Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - MarketBeat
RYTMRhythm Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Trend Tracker for (RYTM) - Stock Traders Daily
Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome - GlobeNewswire
Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024 - The Manila Times
Guggenheim Initiates Coverage of Rhythm Pharmaceuticals (RYTM) with Buy Recommendation - MSN
Guggenheim Initiates Coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) - MarketBeat
SG Americas Securities LLC Sells 26,208 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stake Lowered by Wedge Capital Management L L P NC - MarketBeat
Bank of America Increases Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $52.00 - MarketBeat
(RYTM) Technical Data - Stock Traders Daily
Q3 2024 EPS Estimates for Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Cut by Analyst - MarketBeat
Rhythm Pharmaceuticals Announces New Employment Inducement Grants - GlobeNewswire
Rhythm Pharmaceuticals shares stay on H.C. Wainwright’s buy list with focus on niche obesity treatments - Investing.com UK
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given "Buy" Rating at HC Wainwright - MarketBeat
Navigating 5 Analyst Ratings For Rhythm Pharmaceuticals - Benzinga
Squarepoint Ops LLC Lowers Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
AQR Capital Management LLC Acquires 32,831 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Boosts Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Down 4% - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Bought by Marshall Wace LLP - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Acquired by Algert Global LLC - MarketBeat
Perceptive Advisors LLC Raises Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Frazier Life Sciences Management L.P. Increases Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Driehaus Capital Management LLC Raises Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Profund Advisors LLC - MarketBeat
Canada Pension Plan Investment Board Has $17.12 Million Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat
Is Rhythm Pharmaceuticals (NASDAQ:RYTM) Using Debt Sensibly? - Simply Wall St
Rhythm: Upcoming sNDA Label Expansion IMCIVREE Isn't Only Catalyst On Deck (NASDAQ:RYTM) - Seeking Alpha
Long Term Trading Analysis for (RYTM) - Stock Traders Daily
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish - Insider Monkey
Rhythm Pharmaceuticals Inc. [RYTM] Shares Jump Approximately 128.63% Over the Year - Knox Daily
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):